Compare Arista Networks Inc (ANET) vs Church & Dwight Co., Inc. (CHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arista Networks Inc vs Church & Dwight Co., Inc. — how do they compare? Arista Networks Inc trades at $199.51 (market cap $241.55B), while Church & Dwight Co., Inc. trades at $102.84 (market cap $24.50B). The key difference: Arista Networks Inc is far larger — about 9.9× Church & Dwight Co., Inc.'s market cap, and Church & Dwight Co., Inc. pays a 1.19% dividend while Arista Networks Inc pays none. Which is the better fit depends on your goals.
| ANET | CHD | |
|---|---|---|
Market Cap | $241.55B | $24.50B |
Sector | Technology | Consumer Staples |
52-Week High | $197.85 | $105.26 |
52-Week Low | $116.13 | $81.60 |
Enterprise Value | $228.21B | $26.50B |
Dividend Yield | — | 1.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arista Networks (ANET) trades at $188.67, down 1.9% over 24 hours, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, with revenue growing from $4.4B in 2022 to $9.0B in 2025 and a net income margin of 38.37%. Recent earnings beats and raised 2026 guidance reflect robust AI-driven demand from hyperscalers like Meta and Microsoft.
Outlook remains positive due to AI data center expansion and Ethernet market growth, but high valuation multiples (P/E 59.71) pose risks if execution falters. Analyst consensus is strongly bullish with a $252.25 price target, though insider selling and competition require monitoring for sustained gains.
Church & Dwight (CHD) trades at $103.24, slightly below the consensus price target of $103.57, with a modest 24-hour decline of 0.12%. The stock exhibits a bullish technical trend, supported by moving averages, while fundamentals show steady revenue growth to $6.20 billion in 2025 and a net income margin of 11.96%. Recent Q2 2026 earnings matched estimates with organic sales growth of 5.8%, prompting raised full-year guidance. Analyst sentiment is positive with 53% buy ratings, though valuation multiples like a P/E of 33.09 suggest premium pricing.
The outlook remains favorable due to strong brand performance and raised earnings guidance, but risks include elevated debt levels and competitive pressures in consumer staples. Institutional activity shows mixed positions, with some funds reducing stakes. The stock's upside is capped by high valuations, requiring sustained earnings growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arista Networks Inc
Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →About Church & Dwight Co., Inc.
Church & Dwight is the leading producer of baking soda in the world. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion, Orajel, and WaterPik, which together with Arm & Hammer constitute more than 80% of its annual sales and profits. In early 2019, the firm announced the addition of Flawless, which manufactures electric shaving products for women. At the end of 2020, the firm acquired Zicam, a leading brand in the cough/cold-shortening category. Church & Dwight derives more than 80% of its sales from its home market in the U.S.
Read more on CHD →
